EQUITIES
Robust. Fundamental. Dynamic.
Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.
£168.4bn
Equities Assets Under Management
153
Equities Investment
Professionals
20
Average Years’ Financial
Industry Experience
As at 31 March 2025
£168.4bn |
153 |
20 |
As at 31 March 2025
We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.
Featured strategies
Equities Strategies
US
- US Concentrated Growth
- US Mid Cap Growth
- US Mid Cap Value
- US Research Core Equity
- US Research Growth Equity
- US Small Cap Growth
- US Small Cap Value
- US SMID Cap Growth
- US SMID Cap Value
Specialty
- Biotechnology Innovation
- Global Life Sciences
- Global Property Equities
- Global Small Cap
- Global Sustainable Equity
- Global Technology and Innovation
- Global Technology Leaders
Emerging Markets
Asia Pacific
Insights
Global Perspectives: Cross-asset collaboration during market volatility
A discussion on how market volatility creates opportunity for collaborative multi-asset teams and where we are finding value in equity and fixed income today.
Trump’s move to slash U.S. drug prices creates uncertainty for pharma stocks
Assessing the potential impact of President Trump’s “most favored nation” drug pricing policy on biopharma companies.
UK equities: Is it time for a long overdue re-evaluation?
Amidst global uncertainties, UK equities are showing resilience, supported by the potential for better-than-expected UK economic growth.
Institutional Insights
Sign up to get relevant content delivered straight to your inbox.